GlassScriptPhysician profile
Jennifer Argumedo
NPI 1043494826
$26,242.18
in general payments reported to CMS, 2019-2025
23 companies · $411 in 2025
The $411 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $925 · 2021: $54.24 · 2022: $271 · 2023: $229 · 2024: $209 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801 · Education: $46.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.49 |
| Education | $46.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18,903.94 | 2019-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $4,422.22 | 2019-2020 | |
| Lilly USA, LLC | $535.38 | 2019-2023 | Mounjaro, Humalog |
| Astrazeneca Pharmaceuticals LP | $518.92 | 2019-2020 | |
| Dexcom, INC. | $391.51 | 2019-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $330.48 | 2019-2020 | |
| Corcept Therapeutics | $280.23 | 2019-2025 | Korlym |
| Insulet Corporation | $243.57 | 2019-2020 | |
| Medtronic Minimed, INC. | $116.75 | 2019 | |
| Radius Health, INC. | $98.27 | 2019-2024 | Tymlos |
| Mannkind Corporation | $95.04 | 2019-2022 | |
| Glaxosmithkline, LLC. | $46.84 | 2020 | |
| Valeritas, INC. | $39.90 | 2019 | |
| Amgen INC. | $32.97 | 2019 | |
| Tandem Diabetes Care, INC. | $31.26 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $29.03 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.37 | 2019 | |
| Intuity Medical INC | $23.81 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Companion Medical, INC. | $21.10 | 2020 | |
| Merck Sharp & Dohme LLC | $16.74 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.21 | 2020 | |
| Ibsa Pharma INC. | $12.37 | 2020 | |
| Alexion Pharmaceuticals, INC. | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Argumedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.